Oragenics (OGEN) Stock Chart & Stock Price History → Kiss of death from Joe Biden (From Porter & Company) (Ad) Free OGEN Stock Alerts $2.02 -0.02 (-0.98%) (As of 05/31/2024 ET) Add Compare Share Share ChartStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends Oragenics Stock Price Performance5 Day Performance-4.72%1 Month Performance+92.36%3 Month Performance+41.26%6 Month Performance-35.15%Year-To-Date Performance-64.10%1 Year Performance-33.99% Receive OGEN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter Email Address Ad Paradigm PressDems have chosen Biden replacement?On November 16, 2023… Joe Biden accidentally revealed the name of the candidate… Who will replace him in the 2024 presidential election.See who it is HERE. OGEN Stock Chart for Sunday, June, 2, 2024 OGEN Chart by TradingView Oragenics Share Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization05/31/2024$2.04$2.02-0.74%$2.13$1.9815,923 shs$9.05 million05/30/2024$1.97$2.04+3.30%$2.09$2.0020,994 shs$9.12 million05/29/2024$2.12$1.97-7.08%$2.14$1.9631,414 shs$8.83 million05/28/2024$2.22$2.12-4.50%$2.23$2.0550,448 shs$9.50 million05/27/2024$2.22$2.22$2.36$2.1644,300 shs$9.95 million05/24/2024$2.18$2.23+2.29%$2.36$2.1244,377 shs$9.99 million Get the Latest News and Ratings for OGEN and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. 05/23/2024$2.51$2.18-13.15%$2.50$2.1051,537 shs$9.77 million05/22/2024$3.04$2.51-17.43%$2.98$1.50835,938 shs$11.25 million05/21/2024$3.09$3.04-1.62%$3.20$2.76213,761 shs$13.62 million05/20/2024$2.33$3.09+32.62%$3.43$2.381.20 million shs$13.85 million05/17/2024$1.63$2.33+42.94%$2.40$1.60522,449 shs$10.44 million05/16/2024$1.64$1.63-0.61%$1.82$1.59129,572 shs$7.30 million05/15/2024$1.65$1.64-0.30%$1.74$1.5070,682 shs$7.35 million05/14/2024$1.50$1.65+9.67%$1.71$1.5082,439 shs$7.37 million05/13/2024$1.84$1.50-18.48%$2.23$1.41327,666 shs$6.72 million05/10/2024$1.38$1.82+31.88%$1.89$1.40433,714 shs$8.15 million05/09/2024$1.26$1.38+9.96%$1.40$1.18110,877 shs$6.18 million05/08/2024$1.34$1.26-6.34%$1.39$1.2088,280 shs$5.62 million05/07/2024$1.08$1.34+24.07%$1.55$1.13584,055 shs$6.00 million05/06/2024$1.07$1.08+0.93%$1.18$1.0636,919 shs$4.84 million05/03/2024$1.05$1.07+1.90%$1.07$1.0315,657 shs$4.79 million05/02/2024$1.02$1.05+2.95%$1.07$1.029,432 shs$4.70 million05/01/2024$1.04$1.02-1.45%$1.04$1.019,019 shs$4.57 million04/30/2024$1.01$1.04+2.48%$1.06$1.027,273 shs$4.64 million04/29/2024$1.03$1.01-1.94%$1.07$1.0035,408 shs$4.53 million04/26/2024$1.06$1.03-2.83%$1.08$1.0143,752 shs$4.62 million04/25/2024$1.10$1.06-3.64%$1.15$1.0559,496 shs$4.75 million04/24/2024$1.09$1.10+0.92%$1.10$1.079,180 shs$4.93 million04/23/2024$1.06$1.09+2.83%$1.09$1.0318,820 shs$4.88 million04/22/2024$1.13$1.06-6.19%$1.13$1.0415,021 shs$4.75 million04/19/2024$1.15$1.13-1.74%$1.22$1.1315,250 shs$5.06 million04/18/2024$1.08$1.15+6.48%$1.16$1.1123,236 shs$5.15 million04/17/2024$1.08$1.08$1.14$1.0271,800 shs$4.84 million04/16/2024$1.22$1.08-11.48%$1.24$1.05123,527 shs$4.84 million04/15/2024$1.23$1.22-0.81%$1.30$1.1541,764 shs$5.47 million04/12/2024$1.23$1.21-1.63%$1.25$1.1819,784 shs$5.42 million04/11/2024$1.20$1.23+2.50%$1.29$1.1847,836 shs$5.51 million04/10/2024$1.27$1.20-5.51%$1.42$1.17168,478 shs$5.38 million04/09/2024$1.33$1.27-4.51%$1.33$1.2746,333 shs$5.69 million04/08/2024$1.16$1.33+14.66%$1.33$1.1780,987 shs$5.96 millionWho are Nvidia’s New Silent Partners? (Ad)Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.I call these Nvidia’s “Silent Partners.”04/05/2024$1.19$1.16-2.52%$1.27$1.16100,922 shs$5.20 million04/04/2024$1.32$1.19-9.85%$1.38$1.16107,129 shs$5.33 million04/03/2024$1.47$1.32-10.20%$1.49$1.30119,642 shs$5.91 million04/02/2024$1.45$1.47+1.38%$1.48$1.4052,384 shs$6.59 million04/01/2024$1.44$1.45+0.69%$1.48$1.4031,207 shs$6.50 million03/29/2024$1.44$1.44$1.47$1.4025,707 shs$6.45 million03/28/2024$1.40$1.44+2.86%$1.47$1.4025,646 shs$6.45 million03/27/2024$1.39$1.40+0.72%$1.45$1.3836,278 shs$6.27 million03/26/2024$1.42$1.39-2.11%$1.45$1.3961,002 shs$6.23 million03/25/2024$1.47$1.42-3.40%$1.49$1.4130,875 shs$6.36 million03/22/2024$1.44$1.48+2.78%$1.48$1.4241,771 shs$6.63 million03/21/2024$1.38$1.44+4.35%$1.47$1.3840,809 shs$6.45 million03/20/2024$1.43$1.38-3.16%$1.41$1.3623,284 shs$6.18 million03/19/2024$1.41$1.43+1.06%$1.45$1.4130,744 shs$6.38 million03/18/2024$1.40$1.41+0.71%$1.45$1.26217,127 shs$6.32 million03/15/2024$1.44$1.40-2.78%$1.49$1.4034,222 shs$6.27 million03/14/2024$1.46$1.44-1.37%$1.45$1.4021,218 shs$6.45 million03/13/2024$1.43$1.46+2.10%$1.47$1.4033,360 shs$6.54 million03/12/2024$1.43$1.43$1.49$1.4146,000 shs$6.41 million03/11/2024$1.46$1.43-2.05%$1.51$1.4373,202 shs$6.41 million03/08/2024$1.48$1.48-0.01%$1.50$1.4358,839 shs$6.63 million03/07/2024$1.46$1.48+1.38%$1.50$1.4388,717 shs$4.56 million03/06/2024$1.44$1.46+1.39%$1.50$1.4067,898 shs$4.50 million03/05/2024$1.46$1.44-1.37%$1.50$1.39204,218 shs$3.70 million03/04/2024$1.43$1.46+2.10%$1.47$1.4093,906 shs$3.75 million03/01/2024$1.43$1.43$1.47$1.39181,718 shs$3.68 million Related Companies: Acurx Pharmaceuticals Stock Chart Xilio Therapeutics Stock Chart Eyenovia Stock Chart VYNE Therapeutics Stock Chart Fortress Biotech Stock Chart Marker Therapeutics Stock Chart Lipocine Stock Chart Cara Therapeutics Stock Chart Unicycive Therapeutics Stock Chart ProMIS Neurosciences Stock Chart Receive OGEN Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter. This page (NYSE:OGEN) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProDems have chosen Biden replacement?Paradigm PressBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsWrite this ticker symbol down…StocksToTrade Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oragenics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.